NCT02631005
- Conditions
- Autoimmune Diseases, Behavior, Connective Tissue Diseases, +5 more
- Locations
-
- UNC Rheumatology Clinic Chapel Hill, North Carolina, United States
Clinical trial condition
Systemic Lupus Erythematosus
Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.
484 public trials
112 recruiting studies
Systemic Lupus Erythematosus trial results
NCT01408576
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- 539 Birmingham, Alabama, United States
- 557 Little Rock, Arkansas, United States
- 515 Hemet, California, United States
- 544 Huntington Beach, California, United States
NCT01262365
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- 069 Birmingham, Alabama, United States
- 063 Little Rock, Arkansas, United States
- 085 Escondido, California, United States
- 031 Los Angeles, California, United States
NCT01597492
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Paradise Valley, Arizona, United States
- GSK Investigational Site Shreveport, Louisiana, United States
- GSK Investigational Site Baltimore, Maryland, United States
NCT02535689
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01205438
- Conditions
- Autoimmune Disease, Autoimmune Diseases, Connective Tissue Disease, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anniston, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gilbert, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States
NCT00418587
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Medical University of South Carolina Charleston, South Carolina, United States
NCT01837875
- Conditions
- Autoimmune Diseases, Behavior, Behavioral Symptoms, +6 more
- Locations
-
- Institute for Partnerships to Eliminate Health Disparities, University of South Carolina Columbia, South Carolina, United States
NCT01196091
- Conditions
- Autoimmune Disease, Autoimmune Diseases, Connective Tissue Disease, +5 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mesa, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paradise Valley, Arizona, United States
Completed
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
NCT01484496
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Peoria, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States